Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension

被引:0
|
作者
Toth, K
Nemes, J
Czopf, L
Kapronczay, P
Kesmarky, G
Juricskay, I
机构
[1] Univ Pecs, Sch Med, Dept Med 1, Div Cardiol, H-7643 Pecs, Hungary
[2] Univ Pecs, Sch Med, Dept Med 1, Div Endocrinol, H-7643 Pecs, Hungary
关键词
essential hypertension; blood rheology; plasma lipids; doxazosin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is known from previous studies that hemorheological parameters are altered in patients with essential hypertension. The hemorheological and hemodynamical effects of doxazosin, a selective alpha-1-adrenoreceptor blocker agent, was examined in twenty patients (mean age: 54 +/- 10 years) with essential hypertension. Hemorheologic (hematocrit, fibrinogen, plasma and whole blood viscosity) and hemodynamic (cardiac output and index, total peripheral resistance) parameters and plasma lipids were determined. The measurements were carried out before the beginning of the treatment, after 1 week and after 12 weeks treatment periods. Besides significant reduction of blood pressure and total peripheral resistance (p < 0.001), a decrease in cholesterol (p < 0.001) and triglyceride (p < 0.01) levels and a beneficial effect on hemorheological parameters was detected. Fibrinogen and plasma viscosity decreased significantly (p < 0.01). Hematocrit value was also lower after one week (p < 0.001), then an increase could be seen. Whole blood viscosity showed similar changes as hematocrit, but the degree of its final increase was slighter, which was supported by the significantly lower value of corrected blood viscosity (p < 0.05).
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [31] HEMORHEOLOGICAL ABNORMALITIES IN ESSENTIAL-HYPERTENSION
    LORIENTROUDAUT, MF
    ROUDAUT, R
    FREYBURGER, G
    DALLOCCHIO, M
    BOISSEAU, MR
    CLINICAL HEMORHEOLOGY, 1987, 7 (03): : 537 - 537
  • [32] COMPARATIVE EFFECTS OF DIFFERENT VASOACTIVE COMPOUNDS ON HEMORHEOLOGICAL AND BASIC HEMODYNAMIC PARAMETERS
    MARTINO, F
    MAIGNAN, MF
    ROUX, J
    GULATI, OP
    CLINICAL HEMORHEOLOGY, 1987, 7 (03): : 447 - 447
  • [33] IMMEDIATE HEMODYNAMIC-EFFECTS OF URAPIDIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    KOBRIN, I
    AMODEO, C
    VENTURA, HO
    MESSERLI, FH
    FROHLICH, ED
    AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06): : 722 - 725
  • [34] HEMODYNAMIC AND METABOLIC EFFECTS OF PHYSICAL TRAINING IN 4 PATIENTS WITH ESSENTIAL HYPERTENSION
    JOHNSON, WP
    GROVER, JA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1967, 96 (12) : 842 - &
  • [35] Hemodynamic and antihypertensive effects of felodipine in patients with essential hypertension: A pilot study
    Ono, Y
    Mizuno, K
    Goto, M
    Hashimoto, S
    Watanabe, T
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (07): : 392 - 401
  • [36] HEMORHEOLOGICAL ABNORMALITIES IN ESSENTIAL-HYPERTENSION
    LORIENTROUDAUT, MF
    ROUDAUT, R
    FREYBURGER, G
    DALLOCCHIO, M
    BOISSEAU, MR
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (11) : 1983 - 1983
  • [37] ACUTE AND CHRONIC HEMODYNAMIC-EFFECTS OF DOXAZOSIN IN HYPERTENSION AT REST AND DURING EXERCISE
    LUNDJOHANSEN, P
    OMVIK, P
    HAUGLAND, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 : S45 - S54
  • [38] Effects of Valsartan on Lipid and glucose metabolism in patients with essential hypertension
    Hua, Q
    Li, DB
    Chen, HL
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 118A - 118A
  • [39] Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension
    Varani, K
    Manfredini, R
    Iannotta, V
    Pancaldi, C
    Cattabriga, E
    Uluoglu, C
    Borea, PA
    Portaluppi, F
    HYPERTENSION, 2002, 40 (06) : 909 - 913
  • [40] EFFECTS OF DIURETICS ON LIPID-METABOLISM IN PATIENTS WITH ESSENTIAL HYPERTENSION
    CHRYSANT, SG
    NELLER, GK
    DILLARD, B
    FROHLICH, ED
    ANGIOLOGY, 1976, 27 (12) : 707 - 711